DR. DANIEL RIVLIN, MD

MIAMI BEACH, FL

Research Active
Dermatology - MOHS-Micrographic Surgery NPI registered 21+ years 11 publications 1978 – 2025 NPI: 1073518692
Biomarkers, TumorDiagnosis, DifferentialSkin NeoplasmsFacial NerveConsensusBasal Cell CarcinomaCosmetic TechniquesSkin AgingMohs SurgeryMicrophthalmia-Associated Transcription FactorPerivascular Epithelioid Cell NeoplasmsSOXE Transcription Factorsgp100 Melanoma AntigenClofazimineDapsone

Practice Location

4308 ALTON RD
MIAMI BEACH, FL 33140-2840

Phone: (305) 674-8865

What does DANIEL RIVLIN research?

Dr. Rivlin studies rare skin cancers, including Merkel cell carcinoma and trichoblastic carcinoma, focusing on their diagnosis and treatment. He has also researched conditions like histoid leprosy and explored non-surgical methods for improving neck appearance and reducing wrinkles. By analyzing various treatment approaches and patient outcomes, his work aims to provide better care for patients with unusual skin tumors and enhance available treatment options for skin cancers and cosmetic issues.

Key findings

  • Patients with Merkel cell carcinoma may experience a recurrence up to nine years after initial treatment, indicating the need for longer monitoring beyond three years.
  • In a case study, trichoblastic carcinoma was successfully treated with Mohs micrographic surgery, presenting an effective option for this difficult-to-diagnose cancer.
  • For histoid leprosy, a review of 62 cases showed excellent treatment results and minimal side effects, regardless of treatment duration (12 or 24 months).
  • A multicenter trial found that 17 out of 18 patients experienced noticeable improvement in neck banding through a new technique called radiofrequency ablation, with minimal side effects.
  • In a case study of glabellar line treatment, radiofrequency successfully numbed the nerves for over two years with controlled heating and minimal pain.

Frequently asked questions

Does Dr. Rivlin study skin cancer?
Yes, Dr. Rivlin researches various rare skin cancers such as Merkel cell carcinoma, trichoblastic carcinoma, and perivascular epithelioid cell tumors.
What treatments has Dr. Rivlin researched?
Dr. Rivlin has explored treatments for rare skin cancers, effective options for histoid leprosy, and innovative non-surgical techniques for cosmetic improvements.
Is Dr. Rivlin's work relevant to patients with rare skin conditions?
Yes, his research specifically addresses treatment and diagnosis for rare skin conditions, helping both patients and doctors understand and manage these diseases more effectively.
What advances has Dr. Rivlin made in cosmetic treatments?
He has studied techniques like radiofrequency ablation for neck rejuvenation and wrinkle reduction, offering non-invasive options with lasting results.
How can Dr. Rivlin's findings impact patient care?
His findings provide critical insights into the long-term monitoring of skin cancer patients and highlight effective treatment options for rare skin conditions, improving overall patient care.

Publications in plain English

Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis.

2025

Cureus

Kubicki SL, Forbes Kaprive J, Kwong A, Rivlin D, Emerson CM

Plain English
This study looked at a case of Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, that returned almost ten years after the patient was first treated. Specifically, a 66-year-old man had cancer spread to other parts of his body nine years after his initial diagnosis and treatment. The findings stress the need for doctors to monitor patients for longer than the current three-year guideline, as late recurrence can happen, even if it is rare. Who this helps: This information benefits patients with Merkel cell carcinoma and their doctors.

PubMed

Trichoblastic Carcinoma in the Glabella Treated With Mohs Micrographic Surgery.

2024

Cureus

Park L, Crasto D, Kubicki SL, Rivlin D

Plain English
This study focused on a rare skin cancer called trichoblastic carcinoma (TBC), which can sometimes be mistaken for benign cysts. The authors present a case where TBC was successfully treated with a specialized surgery known as Mohs micrographic surgery. This is important because it highlights an effective treatment option for a cancer that can be challenging to diagnose and manage. Who this helps: Patients with trichoblastic carcinoma and doctors treating this rare skin cancer.

PubMed

Tadalafil to improve cutaneous flap perfusion in smokers: A case series and literature review.

2021

JAAD case reports

Matin T, Seyffert J, Katz B, Rivlin D

PubMed

Primary cutaneous perivascular epithelioid cell tumors: two cases and a review of the literature.

2021

Dermatology online journal

Wong J, Mammino J, Seyffert J, Schmits K, Marks E +1 more

Plain English
This study looked at two rare skin tumors called perivascular epithelioid cell tumors, or PEComas, which are not commonly found in the skin with only 23 cases reported previously. The researchers found that these tumors can resemble more common skin growths, making it important for doctors to carefully analyze these tumors to ensure correct diagnosis. Understanding PEComas is crucial because it can help provide better treatment options for patients who might be misdiagnosed. Who this helps: This helps patients who have unusual skin tumors and their doctors.

PubMed

Treatment of histoid leprosy: a lack of consensus.

2020

International journal of dermatology

Bartos G, Sheuring R, Combs A, Rivlin D

Plain English
Researchers looked at how well different treatments work for histoid leprosy, a rare type of leprosy. They reviewed 165 published articles and found that most of the 62 cases studied had excellent results with minimal side effects, regardless of whether treatment lasted for 12 or 24 months. This is important because it shows that the standard therapy used for leprosy is effective for this variant, but we still don't know the best treatment length. Who this helps: This helps patients with histoid leprosy and their doctors by providing information on effective treatment options.

PubMed

Novel Modality for Neck Rejuvenation: A Prospective Multicenter Trial of Percutaneous Radiofrequency Ablation of the Cervical Branch of the Facial Nerve.

2018

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Rivlin D, Skinner DR, Steinmetz-Rodriguez CY, Fabrikant JS, Stoddard MA +3 more

Plain English
The study looked at a new method for improving the appearance of the neck by using a technique called radiofrequency ablation on the nerve that controls neck muscles. Out of 18 patients treated, 17 saw noticeable improvement in neck banding after the procedure, which caused no significant side effects. This is important because it provides a safe, non-surgical alternative to traditional neck rejuvenation options, with little recovery time needed. Who this helps: This benefits patients seeking less invasive ways to enhance their neck appearance.

PubMed

Percutaneous Selective Neuromodulation via Monopolar Radiofrequency for Glabellar Lines: A Case Study.

2016

Journal of drugs in dermatology : JDD

Rivlin D

Plain English
This study explored a new technique using radiofrequency to treat frown lines between the eyebrows, known as glabellar lines. A 48-year-old woman received this treatment, which successfully numbed the nerves in that area for over two years. The procedure involved controlled heating of the nerve, resulting in minimal pain and long-lasting effects. Who this helps: Patients seeking a longer-lasting solution for facial wrinkles.

PubMed

Hematoxylin and safranin O staining of frozen sections.

2000

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Tran D, Golick M, Rabinovitz H, Rivlin D, Elgart G +1 more

Plain English
This study looked at two different staining methods for frozen tissue samples used in skin cancer diagnosis: the common hematoxylin and eosin method and the less expensive safranin O method. The researchers found that safranin O could provide similar or even better accuracy for diagnosing basal and squamous cell carcinomas. This is important because it could lead to more cost-effective and safe options for diagnosing skin cancers. Who this helps: This helps doctors and patients by providing a potentially better and cheaper method for diagnosing skin cancers.

PubMed

The actinic comedonal plaque.

1997

Cutis

Hauptman G, Kopf A, Rabinovitz HS, Oliviero M, Rivlin D

Plain English
This study looks at a specific skin condition called actinic comedonal plaque, which can cause bumps on the skin due to sun damage. The researchers examined a case in detail and described its unique features when viewed under a microscope. Understanding this condition is important because it helps doctors recognize and treat it effectively. Who this helps: This helps patients with skin issues caused by sun exposure.

PubMed

Reconstruction of the nose utilizing a bilobed flap.

1994

International journal of dermatology

Moy RL, Grossfeld JS, Baum M, Rivlin D, Eremia S

Plain English
This study looked at a surgical technique called the bilobed flap for repairing defects in the lower nose, which can be tricky because this area is sensitive and hard to work with. Out of 171 patients, only 3% developed infections, 7% had parts of the flap die, and 5% experienced issues like unevenness or visible scars, but overall, the results were mostly good with excellent color match and shape. This matters because it shows that the modified bilobed flap is a reliable option for nose reconstruction with fewer complications. Who this helps: This helps patients needing nose repairs, especially those recovering from skin cancer or injuries.

PubMed

[Anato-topographic variations of the common bile duct].

1978

Harefuah

Kott I, Rivlin D, Hadad M, Urca I

PubMed

Frequent Co-Authors

Shelby L Kubicki Jennifer Seyffert Jessica Forbes Kaprive Andrew Kwong Colleen M Emerson Lily Park David Crasto Jennifer Wong Jason Mammino Kristen Schmits

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.